CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

You are here

Products

Products

back to search results

Cytokeratin HMW [34BE12]

Product information References Bioinformatics Documents
Product group: Primary
Monoclonal/ Polyclonal: Monoclonal
Clone: 34bE12
Host: Mouse
Isotype: IgG1
Application: Flow cytometry (FC), Immunocytochemistry (ICC),Immunofluorescence (IF), Immunohistochemistry (IHC)
Application notes: Prediluted
Conjugation Type: Unconjugated
Lightchain type: Kappa
Reactivity: Human, Mouse
General notes: Localization: cytoplasm, membrane.
Buffer: proteinase K or trypsin 5-10 min at 37°C
UNSPSC code: 12352203

The antibody reacts with keratins 1,5,10, and 14. In normal tissue, the antibody labels squamous, ductal, and other complex epithelia. The antibody has variable positivity to adenocarcinomas. The most useful application of the antibody was described in the differential diagnosis of basal cell hyperplasia and atypical adenomatous hyperplasia of the prostate. The antibody labels benign basal cells of prostate acinibut not prostate adenocarcinoma. In thyroid neoplasm, positivity was reported to be confined to papillary carcinoma, whereas follicular neoplasms are negative. This antibody, when incorporated into a panel of antibodies, aids in the differrential diagnosis of anaplastic tumors of unknown origin. (Shipping Cost: €200.00)

Cytokeratin HMW [34BE12]

The antibody reacts with keratins 1,5,10, and 14. In normal tissue, the antibody labels squamous, ductal, and other complex epithelia. The antibody has variable positivity to adenocarcinomas. The most useful application of the antibody was described in the differential diagnosis of basal cell hyperplasia and atypical adenomatous hyperplasia of the prostate. The antibody labels benign basal cells of prostate acinibut not prostate adenocarcinoma. In thyroid neoplasm, positivity was reported to be confined to papillary carcinoma, whereas follicular neoplasms are negative. This antibody, when incorporated into a panel of antibodies, aids in the differrential diagnosis of anaplastic tumors of unknown origin.